Friday, September 29, 2023


Biotechnology News Magazine

Palette Life Sciences Announces the Establishment of a Wholly Owned Subsidiary in Japan

Expansion will allow for Palette Life Sciences to provide better support to healthcare providers in Japanese market

Latest Posts

Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

Airway Therapeutics began recruiting patients on March 28, 2023, for daily treatment up to 7 days at the highest dose of zelpultide alfa (rhSP-D) following a Data Safety Monitoring Committee (DSMC) report of no safety concerns.

Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care

At the global HIMSS1 Conference, Roche showcases navify Algorithm Suite, a single platform offering clinicians access to medical algorithms generating insights to help improve care decisions.

PathO3Gen Solutions UVZone® Proven 99.9993% Effective Against Candida Auris: Shoes and Floors in Healthcare Facilities Should Be Addressed as Outbreak Continues

PathO3Gen Solutions’ multi-patented UVZone Shoe Sanitizing Stations, when placed in high-traffic and high-risk areas, enhance healthcare facility infection control measures, and may improve overall hospital biosafety.

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

Under the terms of Pharming's 2019 exclusive license agreement with Novartis for leniolisib, the corresponding first commercial sale of Joenja® triggers a $10 million milestone payment by Pharming to Novartis.

Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes, today announced the establishment of a wholly owned subsidiary located in Tokyo, Japan to commercialize Palette’s portfolio of medical products.

As of January 1, 2022, Palette Life Sciences Japan K.K. has been cleared to distribute Deflux® directly to customers throughout the country. In addition, Palette Life Sciences is working to expand its Japanese offering, actively pursuing regulatory clearance for its Barrigel® and Solesta® brands.

Prior to establishing the subsidiary, Palette Life Sciences partnered with local distributors in Japan to provide access to Deflux. Direct representation of Palette’s products in the country will provide enhanced opportunities to better support local physicians through training, education, and practice support.

“Palette Life Sciences has been rapidly expanding its footprint into new markets over the last several years, including Europe, LATAM, Middle East, Australia and now Japan. This new subsidiary enables local Palette experts to directly support healthcare providers and better service the network of organizations using our products throughout the country. We are excited to be making this long-term commitment to the Japanese market,” said Ole Mikkelsen, Chief Operating Officer, Palette Life Sciences.

Palette Life Sciences Japan shipped its first direct orders of Deflux® in early January. Deflux® is the minimally invasive, first-line treatment for vesicoureteral reflux (VUR), a malformation of the ureteral tunnel in the bladder affecting 1% of children worldwide. All of Palette Life Sciences’ products leverage their global rights to Non-Animal Stabilized Hyaluronic Acid (NASHA®), a proprietary hyaluronic acid formulation that has been proven safe and effective and used for more than 20 years in over 50 million medical procedures worldwide.[1]

“It is exciting and a great opportunity to start Palette Life Sciences Japan K.K. to deliver Palette’s product directly to patients and physicians. We will be able to communicate closely with our customers and promote our products very effectively. It will also connect Japan with global resources to provide consistent training and educational support,” said Yoshiki Kawabata, General Manager, Palette Life Sciences Japan.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine